Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi)

Clinical trials sponsored by Fondazione Sisa (societa Italiana Per Lo Studio Della Arteriosclerosi), explained in plain language.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for rare cholesterol disease: can evinacumab shrink dangerous plaque?

Disease control Recruiting now

This study follows about 52 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol and early heart disease. Researchers will compare those who get evinacumab (a cholesterol-lowering antibody) added to their usual t…

Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC